Cite
Corrigendum to "Di-(2-ethylhexyl) phthalate could disrupt the insulin signaling pathway in liver of SD rats and L02 cells via PPARγ" [ Toxicol Appl Pharmacol. 2017; 316:17-26. doi:10.1016/j. taap.2016.12.010].
MLA
Zhang, Wang, et al. “Corrigendum to ‘Di-(2-Ethylhexyl) Phthalate Could Disrupt the Insulin Signaling Pathway in Liver of SD Rats and L02 Cells via PPARγ’ [ Toxicol Appl Pharmacol. 2017; 316:17-26. Doi:10.1016/j. Taap.2016.12.010].” Toxicology & Applied Pharmacology, vol. 449, Aug. 2022, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.taap.2022.116091.
APA
Zhang, W., Shen, X., Zhang, W., Chen, H., Xu, W., & Wei, W. (2022). Corrigendum to “Di-(2-ethylhexyl) phthalate could disrupt the insulin signaling pathway in liver of SD rats and L02 cells via PPARγ” [ Toxicol Appl Pharmacol. 2017; 316:17-26. doi:10.1016/j. taap.2016.12.010]. Toxicology & Applied Pharmacology, 449, N.PAG. https://doi.org/10.1016/j.taap.2022.116091
Chicago
Zhang, Wang, Xin-yue Shen, Wen-wen Zhang, Hao Chen, Wei-ping Xu, and Wei Wei. 2022. “Corrigendum to ‘Di-(2-Ethylhexyl) Phthalate Could Disrupt the Insulin Signaling Pathway in Liver of SD Rats and L02 Cells via PPARγ’ [ Toxicol Appl Pharmacol. 2017; 316:17-26. Doi:10.1016/j. Taap.2016.12.010].” Toxicology & Applied Pharmacology 449 (August): N.PAG. doi:10.1016/j.taap.2022.116091.